Securian Asset Management Inc. decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 8,063 shares of the semiconductor company’s stock after selling 134 shares during the quarter. Securian Asset Management Inc.’s holdings in Synopsys were worth $4,134,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in shares of Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after purchasing an additional 346,994 shares during the period. Pictet Asset Management Holding SA lifted its stake in Synopsys by 38.3% during the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after purchasing an additional 673,837 shares during the period. Ameriprise Financial Inc. lifted its stake in Synopsys by 6.6% during the first quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock worth $863,500,000 after purchasing an additional 125,199 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Synopsys by 20.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock worth $778,928,000 after purchasing an additional 305,489 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after purchasing an additional 313,218 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of SNPS stock opened at $459.04 on Wednesday. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $85.27 billion, a price-to-earnings ratio of 36.03, a PEG ratio of 5.00 and a beta of 1.10. The firm’s 50 day moving average is $519.12 and its 200-day moving average is $511.47. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.
Analysts Set New Price Targets
A number of brokerages have commented on SNPS. Needham & Company LLC cut their price target on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Baird R W cut shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Morgan Stanley reduced their price target on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research report on Thursday, September 11th. Finally, Piper Sandler reduced their price target on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. Ten analysts have rated the stock with a Buy rating, five have given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, Synopsys currently has a consensus rating of “Hold” and an average price target of $569.67.
Check Out Our Latest Analysis on SNPS
Insider Buying and Selling at Synopsys
In other Synopsys news, Director Robert G. Painter purchased 350 shares of the company’s stock in a transaction that occurred on Thursday, September 11th. The stock was acquired at an average cost of $425.44 per share, with a total value of $148,904.00. Following the completion of the purchase, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. This represents a 18.03% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the sale, the chief executive officer directly owned 71,615 shares of the company’s stock, valued at approximately $42,181,951.15. This trade represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Expert Stock Trading Psychology Tips
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- Compound Interest and Why It Matters When Investing
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
